| Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism JC Schell, DR Wisidagama, C Bensard, H Zhao, P Wei, J Tanner, A Flores, ... Nature cell biology 19 (9), 1027-1036, 2017 | 276 | 2017 |
| NCCN guidelines insights: genetic/familial high-risk assessment: colorectal, version 2.2019: featured updates to the NCCN guidelines S Gupta, D Provenzale, X Llor, AL Halverson, W Grady, DC Chung, ... Journal of the National Comprehensive Cancer Network 17 (9), 1032-1041, 2019 | 226 | 2019 |
| Screening and prevention of colorectal cancer P Kanth, JM Inadomi Bmj 374, 2021 | 213 | 2021 |
| Hereditary colorectal polyposis and cancer syndromes: a primer on diagnosis and management P Kanth, J Grimmett, M Champine, R Burt, JN Samadder Official journal of the American College of Gastroenterology| ACG 112 (10 …, 2017 | 206 | 2017 |
| Effect of sulindac and erlotinib vs placebo on duodenal neoplasia in familial adenomatous polyposis: a randomized clinical trial NJ Samadder, DW Neklason, KM Boucher, KR Byrne, P Kanth, ... Jama 315 (12), 1266-1275, 2016 | 153 | 2016 |
| NCCN Guidelines® insights: genetic/familial high-risk assessment: colorectal, Version 1.2021: featured updates to the NCCN Guidelines JM Weiss, S Gupta, CA Burke, L Axell, LM Chen, DC Chung, ... Journal of the National Comprehensive Cancer Network 19 (10), 1122-1132, 2021 | 126 | 2021 |
| NCCN Guidelines insights: colorectal cancer screening, version 2.2020: Featured updates to the NCCN guidelines D Provenzale, RM Ness, X Llor, JM Weiss, B Abbadessa, G Cooper, ... Journal of the National Comprehensive Cancer Network 18 (10), 1312-1320, 2020 | 103 | 2020 |
| RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers DA Delker, BM McGettigan, P Kanth, S Pop, DW Neklason, MP Bronner, ... PloS one 9 (2), e88367, 2014 | 97 | 2014 |
| Association of sulindac and erlotinib vs placebo with colorectal neoplasia in familial adenomatous polyposis: secondary analysis of a randomized clinical trial NJ Samadder, SK Kuwada, KM Boucher, K Byrne, P Kanth, W Samowitz, ... JAMA oncology 4 (5), 671-677, 2018 | 81 | 2018 |
| Eflornithine plus sulindac for prevention of progression in familial adenomatous polyposis CA Burke, E Dekker, P Lynch, NJ Samadder, F Balaguer, R Hüneburg, ... New England Journal of Medicine 383 (11), 1028-1039, 2020 | 54 | 2020 |
| Gene signature in sessile serrated polyps identifies colon cancer subtype P Kanth, MP Bronner, KM Boucher, RW Burt, DW Neklason, ... Cancer Prevention Research 9 (6), 456-465, 2016 | 49 | 2016 |
| Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2 K Chang, JA Willis, J Reumers, MW Taggart, FA San Lucas, S Thirumurthi, ... Annals of Oncology 29 (10), 2061-2067, 2018 | 46 | 2018 |
| Serrated polyposis: colonic phenotype, extracolonic features, and familial risk in a large cohort KW Jasperson, P Kanth, AC Kirchhoff, D Huismann, A Gammon, ... Diseases of the colon & rectum 56 (11), 1211-1216, 2013 | 44 | 2013 |
| Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa L Reyes-Uribe, W Wu, O Gelincik, PV Bommi, A Francisco-Cruz, LM Solis, ... Gut 70 (3), 555-566, 2021 | 43 | 2021 |
| Intramucosal lipomas of the colon implicate Cowden syndrome A Caliskan, WK Kohlmann, KE Affolter, E Downs-Kelly, P Kanth, ... Modern Pathology 31 (4), 643-651, 2018 | 27 | 2018 |
| Recommendations for a more organized and effective approach to the early detection of pancreatic cancer from the PRECEDE (pancreatic cancer early detection) consortium TA Gonda, JN Everett, M Wallace, DM Simeone, L Amundadottir, G Beyer, ... Gastroenterology 161 (6), 1751-1757, 2021 | 25 | 2021 |
| Patterns of family communication and preferred resources for sharing information among families with a Lynch syndrome diagnosis J Petersen, C Koptiuch, YP Wu, R Mooney, A Elrick, K Szczotka, ... Patient education and counseling 101 (11), 2011-2017, 2018 | 21 | 2018 |
| Chemoprevention with cyclooxygenase and epidermal growth factor receptor inhibitors in familial adenomatous polyposis patients: mRNA signatures of duodenal neoplasia DA Delker, AC Wood, AK Snow, NJ Samadder, WS Samowitz, KE Affolter, ... Cancer Prevention Research 11 (1), 4-15, 2018 | 19 | 2018 |
| Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the Pancreatic Cancer Early Detection Consortium TA Gonda, J Farrell, M Wallace, L Khanna, E Janec, R Kwon, M Saunders, ... Gastrointestinal endoscopy 95 (4), 723-732. e7, 2022 | 14 | 2022 |
| Genetic/familial high-risk assessment: colorectal, version 2.2019 featured updates to the NCCN guidelines S Gupta, D Provenzale, X Llor, AL Halverson, W Grady, DC Chung, ... JNCCN Journal of the National Comprehensive Cancer Network 17 (9), 1032-1041, 2019 | 14 | 2019 |
